BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
11.75
-0.30 (-2.49%)
Mar 9, 2026, 5:00 PM CET

BioMaxima Company Description

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland.

It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements.

The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form.

In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, autoclave equipment, and pliers and scissors.

BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.

BioMaxima S.A.
Country Poland
Founded 1997
Industry Diagnostics & Research
Sector Healthcare
Employees 135
CEO Lukasz Urban

Contact Details

Address:
ul. Vetterów 5
Lublin, 20-277
Poland
Phone 48 81 440 83 71
Website biomaxima.com

Stock Details

Ticker Symbol BMX
Exchange Warsaw Stock Exchange
Fiscal Year January - December
Reporting Currency PLN
ISIN Number PLBIOMX00015
SIC Code 3845

Key Executives

Name Position
Lukasz Urban President of the Management Board
Henryk Lewczuk Chief Financial Officer and Member of the Management Board
Piotr Janowski Chief Operating Officer and Member of the Management Board
Zaneta Homenda Chief Accounting Officer